Peace in strength.  Like the mighty oak that has survived some 600 years in what is now my back yard, we engage with experience and resilience.  Whether the winds blow hard or the sun shines bright, we go on, deeply rooted and stretching for the heavens.

Strength in peace.  Many challenges of the world, and Pharmaceutical R&D, grow out of mere misunderstandings.  We seek to enhance mutual understanding and peaceful cooperation toward shared objectives.

- Peace and Strength by Kevin Freiert

This Symposium Was Truly Rare

By Kevin Freiert | May 28, 2018 |

Sometimes you get the chance to experience something that resets your expectations. The Salem Oaks team had the opportunity to attend the Rare Patient Advocacy Symposium in Philadelphia on May 19, 2018.  The event was organized in partnership between Global Genes and the Orphan Disease Center at UPenn.  Although I…

Read More

Who would Vote Against Patients’ Right to Try?

By Kevin Freiert | March 31, 2018 |  TweetShareShare0 Shares

Read More

Introducing Salem Oaks: Empowering Patients to Shape the Future of Medicine

By Kevin Freiert | March 9, 2018 |

I remember the day vividly. It was cold and rainy, the night before Thanksgiving. I was sitting in an oncologist’s office and she said those words, “You have cancer and I am not able to treat you. You are going to need to see a specialist.” It was official, I…

Read More

How to Incorporate Family Caregivers in Chronic Care Management

By Kevin Freiert | January 30, 2018 |

We need to help people understand their rights to information (and to privacy) when they choose to help care for a family member. The article points out many barriers to family members effectively assisting in the care of loved ones. This situation seems similar to writing one’s last will and…

Read More

Patient Engagement Strategies Lack Patient Voice, Consumer Input

By Kevin Freiert | January 30, 2018 |

I found this quite ironic.  “Physician, first heal thyself…” TweetShareShare0 Shares

Read More

How many blessings can be squeezed into 20 years?

By Kevin Freiert | January 28, 2018 |

Twenty years ago, today, I woke up and had cancer. I had no idea what the day would bring.  It had been about two months since I was diagnosed with myxoid liposarcoma in my left thigh.  TweetShareShare3030 Shares

Read More

Educating Patients: Taking Action to Refocus and Accelerate

By Kevin Freiert | October 30, 2017 |

Over the past weeks, I have discussed several barriers that make it difficult to involve patients in developing new medicines as much as everyone involved would like. My theory is that we need to do a better job educating patients.  I’d love to hear your thoughts on this topic. Some of these barriers…

Read More

Are We on the Right Track?

By Kevin Freiert | October 16, 2017 |

Choices. Have you ever found yourself in an unfamiliar city trying to get from point A to point B as quickly as possible?  Taxi? Bus? Subway? Traffic scares you, so the subway it is. You stare at the nicely designed kaleidoscope of a map and try to make sense of which…

Read More

No One is Truly Objective

By Kevin Freiert | October 9, 2017 |

As the winter approaches here in New England, the picture above caught my eye. What do you see? Is the sun setting… or rising? What’s up? What’s down? Where was the picture taken? When? How can you be sure? Did my opening line influence you? Introduction There seems to be a consensus from all…

Read More

Fellow Travelers on a Long, Cold Road

By Kevin Freiert | October 2, 2017 |

The journey to a new medicine is a challenging, uphill, and winding road. Whenever a patient gets involved in medicines development, they are likely to face a roller coaster of hopefulness and despair like they have never experienced. Since only about 5% of the compounds and proteins put into advanced testing a…

Read More